Safety and efficacy of insulin aspart versus insulin lispro in insulin pumps in children and adolescents with type 1 diabetes
Latest Information Update: 24 Dec 2016
Price :
$35 *
At a glance
- Drugs Insulin aspart (Primary) ; Insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Novo Nordisk
- 20 May 2009 Actual end date (May 2006) added as reported by ClinicalTrials.gov.
- 01 Feb 2008 Efficacy and tolerability results have been published.
- 23 Aug 2007 Status changed from in progress to completed.